摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(benzo[d][1,3]dioxol-5-yl)-N,N-diethyl-3-(2-hydroxy-4,6-dimethoxyphenyl)propanamide | 958948-29-3

中文名称
——
中文别名
——
英文名称
3-(benzo[d][1,3]dioxol-5-yl)-N,N-diethyl-3-(2-hydroxy-4,6-dimethoxyphenyl)propanamide
英文别名
3-(1,3-benzodioxol-5-yl)-N,N-diethyl-3-(2-hydroxy-4,6-dimethoxyphenyl)propanamide
3-(benzo[d][1,3]dioxol-5-yl)-N,N-diethyl-3-(2-hydroxy-4,6-dimethoxyphenyl)propanamide化学式
CAS
958948-29-3
化学式
C22H27NO6
mdl
——
分子量
401.459
InChiKey
GUOUIGXFEWSFFH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    29
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    77.5
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为产物:
    参考文献:
    名称:
    Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors
    摘要:
    Retinoic acid-related orphan receptor ROR gamma t plays a pivotal role in the differentiation of T(H)17 cells. Antagonizing ROR gamma t transcriptional activity is a potential means to treat T(H)17-related autoimmune diseases. Herein, we describe the identification of a series of diphenylpropanamides as novel and selective ROR gamma antagonists. Diphenylpropanamide 4n inhibited the transcriptional activity of ROR gamma t, but not ROR alpha, in cells. In addition, it suppressed human T(H)17 cell differentiation at submicromolar concentrations.
    DOI:
    10.1021/ml300286h
点击查看最新优质反应信息

文献信息

  • Amido compounds as RORγt modulators and uses thereof
    申请人:New York University
    公开号:US10561666B2
    公开(公告)日:2020-02-18
    Amido compounds are disclosed that have a formula represented by the following: and wherein n1, n2, R1a, R1b, R2, R3, R4, R5, and R6 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune disorders, cancer, and graft-versus-host disease.
    本发明公开了具有下式表示的氨基化合物: 其中 n1、n2、R1a、R1b、R2、R3、R4、R5 和 R6 如本文所述。这些化合物可制备成药物组合物,并可用于预防和治疗包括人类在内的哺乳动物的各种疾病,包括非限制性的炎症、自身免疫性疾病、癌症和移植物抗宿主疾病。
  • AMIDO COMPOUNDS AS RORyT MODULATORS AND USES THEREOF
    申请人:Littman Dan
    公开号:US20130085162A1
    公开(公告)日:2013-04-04
    Amido compounds are disclosed that have a formula represented by the following: and wherein n1, n2, R 1a , R 1b , R 2 , R 3 , R 4 , R 5 , and R 6 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune disorders, cancer, and graft-versus-host disease.
  • AMIDO COMPOUNDS AS RORyt MODULATORS AND USES THEREOF
    申请人:LITTMAN Dan
    公开号:US20170065606A1
    公开(公告)日:2017-03-09
    Amido compounds are disclosed that have a formula represented by the following: and wherein n1, n2, R 1a , R 1b , R 2 , R 3 , R 4 , R 5 , and R 6 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune disorders, cancer, and graft-versus-host disease.
  • US9492439B2
    申请人:——
    公开号:US9492439B2
    公开(公告)日:2016-11-15
  • Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors
    作者:Jun R. Huh、Erika E. Englund、Hang Wang、Ruili Huang、Pengxiang Huang、Fraydoon Rastinejad、James Inglese、Christopher P. Austin、Ronald L. Johnson、Wenwei Huang、Dan R. Littman
    DOI:10.1021/ml300286h
    日期:2013.1.10
    Retinoic acid-related orphan receptor ROR gamma t plays a pivotal role in the differentiation of T(H)17 cells. Antagonizing ROR gamma t transcriptional activity is a potential means to treat T(H)17-related autoimmune diseases. Herein, we describe the identification of a series of diphenylpropanamides as novel and selective ROR gamma antagonists. Diphenylpropanamide 4n inhibited the transcriptional activity of ROR gamma t, but not ROR alpha, in cells. In addition, it suppressed human T(H)17 cell differentiation at submicromolar concentrations.
查看更多